Results 111 to 120 of about 3,177,071 (215)
Psychedelic-assisted therapy: A new way forward in mental health
In the following pages, I will cover many topics relating to psychedelic-assisted therapy. Initially, I explore the historical background of psychedelic use in indigenous communities around the world followed by an introduction of psychedelic-assisted ...
Wibur, Kimberly (Rosie)
core
This paper aims to identify the effects of ayahuasca on humans and more specifically how this substance defines changes within psychological and behavioral patterns, including experience of emotions, decision-making processes, and life changes. The demand for the new-wave of antidepressants based on psychedelic substances places emphasis on the study ...
openaire +1 more source
Psychedelic-assisted grief therapy: a mixed-method case study [PDF]
This paper focuses on a single case of ayahuasca-assisted grief therapy for the prevention of complicated grief, conducted within a clinical trial. The participant, a woman in her thirties who lost her father to cancer, completed a 9-session process of ...
Sabucedo, P +10 more
core +1 more source
Psychedelic-Assisted Therapy (PAT) is a rapidly growing therapeutic approach that to date has rarely considered the nuanced needs of LGBTQA+ individuals.
Riccardo Miceli McMillan +7 more
semanticscholar +1 more source
Psychedelics, psychedelic-assisted therapy and employees’ well-being [PDF]
There is a psychedelic renaissance with key drugs that alter perception and mood being given breakthrough therapy status as potential treatments for common mental health conditions.
Smith, Charlie
core +1 more source
Insurance Coverage for Psychedelic Therapy
As psychedelic-assisted therapies advance through the FDA approval pipeline, the question of who will pay for them is moving from academic to urgent. Experts project that MDMA-assisted therapy for PTSD will cost upwards of $11,000-$12,000 per course of ...
Vincent Joralemon
core +1 more source
Trauma-related disorders and substance use are disproportionately underdiagnosed and undertreated in individuals with High-Functioning Autism (Level 1 Autism Spectrum Disorder), particularly those in underserved or marginalized communities.
Paul Okugo Imoh +5 more
semanticscholar +1 more source
Our aim is to gather empirical evidence regarding mental health practitioners’ (MHPs) readiness, perceived feasibility and ethical concerns regarding the implementation of psychedelic-assisted therapy (PAT) in routine ...
Anna Harwood-Gross, Avigail Zucker
core +6 more sources
BackgroundKetamine-assisted therapy (KaT) has demonstrated therapeutic potential in treating depression, anxiety, and PTSD, driving interest in group-based models of care.
Shannon Dames +5 more
doaj +1 more source
Background and aims: Interest in psychedelic research has grown significantly in recent years and the naturally derived substance psilocybin, in combination with therapy, has shown promising results as a treatment for a range of psychiatric conditions ...
Moa Nordin +7 more
core +1 more source

